Meiling Zhao
Overview
Explore the profile of Meiling Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
492
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun S, Ren J, Zhao M, Wang L, Zheng C, Yang J, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2025 Mar;
2024:1-4.
PMID: 40040077
With the gradual realization of manned spaceflight goals, the physical and mental health of astronauts has become a core concern. Numerous studies in recent years have indicated that the aerospace...
2.
Wang G, Hu N, Hautier Y, Middleton B, Wang M, Zhao M, et al.
Glob Chang Biol
. 2025 Jan;
31(1):e70056.
PMID: 39853886
Maintaining the stability of ecosystems is critical for supporting essential ecosystem services over time. However, our understanding of the contribution of the diverse biotic and abiotic factors to this stability...
3.
Zhang Z, Gao R, Zhao M, Zhang X, Gao H, Qi Y, et al.
J Chem Inf Model
. 2025 Jan;
65(3):1140-1154.
PMID: 39823568
In recent decades, covalent inhibitors have emerged as a promising strategy for therapeutic development, leveraging their unique mechanism of forming covalent bonds with target proteins. This approach offers advantages such...
4.
Li S, Zhou F, Lan H, Cao X, Mogenet A, Diaz-Pena R, et al.
Transl Cancer Res
. 2025 Jan;
13(12):6936-6946.
PMID: 39816561
Background: In the clinic, the primary conventional treatments of advanced non-small cell lung cancer (NSCLC) are surgery, radiation therapy, and chemotherapy. In recent years, immune checkpoint inhibitors (ICIs) have shown...
5.
Zhao M, Hou Y, Yuan M, Ma S, Yue Y
J Cardiothorac Surg
. 2025 Jan;
20(1):43.
PMID: 39773754
Objective: To investigate the therapeutic effect of levosimendan on hemodynamics in patients undergoing major cardiac surgery and presenting with acute postoperative heart failure. Methods: The subjects of the study were...
6.
Wang L, Liu J, Guo Y, Zhao M, Zhang B, Zhang J, et al.
J Multidiscip Healthc
. 2024 Dec;
17:5853-5865.
PMID: 39668888
Purpose: To investigate the outcomes and risk factors for patients with hematologic malignancies (HM) following late-stage SARS-CoV-2 infection. Background: Patients with HM such as lymphoproliferative malignancies (including acute lymphoblastic leukemia...
7.
Wang Z, Du X, Zhang P, Zhao M, Zhang T, Liu J, et al.
Mol Biomed
. 2024 Dec;
5(1):66.
PMID: 39641872
Millions of people worldwide die of acute myeloid leukaemia (AML) each year. Although N6-methyladenosine (mA) modification has been reported to regulate the pathogenicity of AML, the mechanisms by which mA...
8.
Xie L, Zhao M, Zong L, Yue Y
Discov Med
. 2024 Oct;
36(189):2088-2097.
PMID: 39463229
Background: Sepsis often leads to cardiomyopathy, contributing to increased mortality rates. 2,6-Diisopropylphenol (propofol), an anesthetic, has demonstrated efficacy in protecting cardiomyocytes from cell death caused by hypoxia and reoxygenation. This...
9.
Zhao L, Zhao M, Zhou X, Yuan R, Zhong X, Zhuo Y
Food Chem
. 2024 Jul;
458:140202.
PMID: 38954955
Traditional DNA walkers face enormous challenges due to limited biostability and reaction kinetics. Herein, we designed a self-driven close-looped DNAzyme walker (cl-DW) with high structural biostability and catalytic activity that...
10.
Peng X, Zhang X, Zhao M, Chang D, Yang L, Mei H, et al.
Br J Haematol
. 2024 Jun;
205(2):420-428.
PMID: 38887101
Chimeric antigen receptor (CAR)-T-cell therapy has demonstrated considerable efficacy and safety in the treatment of patients with relapsed/refractory haematological malignancies. Owing to significant advances, CAR-T-cell therapeutic modality has undergone substantial...